探花精选

Erland Axelsson's research

The research is focused on behavioral medicine and the interaction between persistent physical symptoms and psychological processes. We strive for a flat organization, with openness and a high tolerance for unexpected, including negative, research findings.

Research focus

Area one, involves transdiagnostic perspectives on groups suffering from persistent physical symptoms such as pain, fatigue, or gastrointestinal issues. Providing support and help for patients with these conditions is one of healthcare鈥檚 greatest challenges. The research program SOMEX aims to understand and develop transdiagnostic exposure-based treatment. Interests also includes measurement methods, for example focusing on symptom preoccupation and health anxiety.

Area two, explores behavioral medicine perspectives on cancer survivorship. As life expectancy increases, approximately 6% of Sweden鈥檚 current population has received a cancer diagnosis at some point. The research program IN-FACT aims to develop evidence-based approaches for psychological support in cases of long-term distress among cancer survivors.

Collaborators and researchers

Graduation projects and new research ideas are welcome.

Collaboration

  • Sandra af Winklerfelt Hammarberg , Christel Hedman, Sigrid Salomonsson, Caroline Wachtler, Anna Nager, John Wallert, Eva Toth-Pal , Elinor Nemlander, 探花精选
  • Nils Gasslander, Uppsala University
  • Steven Nordin, Ume氓 University
  • Michael Witth枚ft, Ruhr University Bochum

Funding

  • 叠谤枚蝉迟肠补苍肠别谤蹿枚谤产耻苍诲别迟
  • Swedish Cancer Society
  • Eva och Oscar Ahr茅ns stiftelse
  • Region Stockholm
  • Signe och Ane Gyllenbergs stiftelse
  • Stiftelsen Professor Bror Gadelius Minnesfond
  • Swedish Research Council

Selected publications


Hybelius J, Af Winklerfelt Hammarberg S, Salomonsson S, Wachtler C, Epstein M, Olsson A, Strand E, S枚derstr枚m Winter L, 脜kerlund T, Bj枚rkander D, Kosic A, Chahin G, Wallert J, Toth-Pal E, Nordin S, Axelsson E
Psychol Med 2025 Aug;55():e226


Hybelius J, Kosic A, Salomonsson S, Wachtler C, Wallert J, Nordin S, Axelsson E
JAMA Netw Open 2024 Nov;7(11):e2446603

Content reviewer:
21-10-2025